# Caprotec Bioanalytics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/caprotec-bioanalytics

- Industry: Biotechnology
- Headquarters: Berlin, Germany
- Website: www.caprotec.com
- Total disclosed funding: $6.4M
- Latest round: Series B (May 9, 2011)
- Investors on record: 3

## About

Caprotec Bioanalytics specializes in advanced bioanalytical solutions, providing innovative technologies that enhance operational efficiency for clients across various sectors, including healthcare and finance.Founded in Berlin, Germany, Caprotec Bioanalytics focuses on delivering bioanalytical solutions. The company secured a SERIES B funding round on May 9, 2011, led by LBBW Venture Capital, raising EUR 1.000 mn. The total amount raised by the company is EUR 1.000 mn, and it currently holds a valuation of EUR 13.944 mn. Caprotec has completed a total of five deals, reflecting a commitment to expanding its market presence.Caprotec Bioanalytics offers a range of innovative solutions designed to address specific challenges faced by sectors such as healthcare, finance, and retail. Their advanced technology systems enhance operational processes and user experiences, focusing on improving efficiency in workflow management, facilitating real-time communication, and optimizing resource allocation. The company primarily markets its products in North America and Europe, targeting cities with high concentrations of their demographics to ensure effective customer reach.Caprotec Bioanalytics generates revenue through direct-to-consumer sales and B2B partnerships. Clients typically subscribe to their software solutions or license technology through annual or monthly payment plans, catering to both small businesses and larger enterprises. The flagship products are essential to their revenue model, fostering long-term customer relationships and ensuring stable income through recurring sales and strategic partnerships.Caprotec Bioanalytics plans to utilize the funds from the SERIES B financing completed in May 2011 to support the development of new products and expand its market presence. The company intends to launch upcoming innovative offerings targeting specific industry needs, focusing on enhancing their existing technologies. Additionally, they aim to penetrate new markets in North America and Europe by the end of 2013, leveraging their recent funding to support these initiatives.

## Funding rounds

- Series B, May 9, 2011, $1.4M — LBBW Venture Capital
- Series B, May 13, 2010, $5M — Creathor Ventures, IBB Ventures

## Investors

- Creathor Ventures (https://capitalatlas.ai/funds/creathor-ventures) — Series B
- IBB Ventures (https://capitalatlas.ai/funds/ibb-ventures) — Series B
- LBBW Venture Capital (https://capitalatlas.ai/funds/lbbw-venture-capital) — Series B